Impact BioMedical, Inc. (IBO)
4.41
-0.27
(-5.77%)
USD |
NYAM |
Oct 07, 12:33
Impact BioMedical EPS Diluted (Quarterly) : -0.0818 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0818 |
| March 31, 2026 | -0.2678 |
| December 31, 2025 | 0.6326 |
| September 30, 2025 | -1.522 |
| June 30, 2025 | -14.86 |
| March 31, 2025 | -1.326 |
| December 31, 2024 | -29.74 |
| September 30, 2024 | 4.659 |
| June 30, 2024 | -0.9753 |
| March 31, 2024 | -1.055 |
| December 31, 2023 | -1.355 |
| September 30, 2023 | -1.275 |
| June 30, 2023 | -1.209 |
| March 31, 2023 | -0.7207 |
| Date | Value |
|---|---|
| December 31, 2022 | -3.876 |
| September 30, 2022 | -2.379 |
| June 30, 2022 | -0.803 |
| March 31, 2022 | -0.7338 |
| December 31, 2021 | 0.3488 |
| September 30, 2021 | -0.8835 |
| June 30, 2021 | -0.3679 |
| March 31, 2021 | -0.5269 |
| December 31, 2020 | -0.2458 |
| September 30, 2020 | -0.1434 |
| June 30, 2020 | -0.1743 |
| March 31, 2020 | -0.0919 |
| September 30, 2019 | -0.0897 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | -1.017 |
| Enveric Biosciences, Inc. | -0.7594 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.70M |
| Revenue (Quarterly) | 0.003M |
| Total Expenses (Quarterly) | 0.702M |
| Enterprise Value | 43.22M |
| Gross Profit Margin (Quarterly) | -9.40K% |
| Profit Margin (Quarterly) | -23.33K% |
| Earnings Yield | -28.11% |
| Normalized Earnings Yield | -31.02 |